awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26767461-851843BF-DF17-4E4F-B1E8-E5156FF56D6C
Q26767461-851843BF-DF17-4E4F-B1E8-E5156FF56D6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767461-851843BF-DF17-4E4F-B1E8-E5156FF56D6C
Advances in Understanding and Managing Chronic Urticaria
P2860
Q26767461-851843BF-DF17-4E4F-B1E8-E5156FF56D6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767461-851843BF-DF17-4E4F-B1E8-E5156FF56D6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46e8681360f927c10fde7a5cf249523f6d37aec2
P2860
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.